Gilead Presents New Data Highlighting Progress in Liver Fibrosis

Go back to Gilead Presents New Data Highlighting Progress in Liver Fibrosis
Gilead Sciences (NASDAQ: GILD) Delayed: 127.88 +4.04 (3.26%)
Previous Close $123.84    52 Week High $108.63 
Open $125.25    52 Week Low $71.39 
Day High $128.70    P/E 70.65 
Day Low $125.00    EPS $1.81 
Volume 19,908,480